Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
  • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
  • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P13/00—Drugs for disorders of the urinary system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P13/00—Drugs for disorders of the urinary system
  • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P5/00—Drugs for disorders of the endocrine system
  • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
  • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
  • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
  • C07K7/04—Linear peptides containing only normal peptide links
  • C07K7/16—Oxytocins; Vasopressins; Related peptides
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K38/00—Medicinal preparations containing peptides

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Medicinal Chemistry (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• Animal Behavior & Ethology (AREA)
• Pharmacology & Pharmacy (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Biochemistry (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Genetics & Genomics (AREA)
• Molecular Biology (AREA)
• Biophysics (AREA)
• Urology & Nephrology (AREA)
• Diabetes (AREA)
• Endocrinology (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Peptides Or Proteins (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Immunology (AREA)
• Gastroenterology & Hepatology (AREA)
• Cell Biology (AREA)
• Toxicology (AREA)
• Zoology (AREA)
• Epidemiology (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=51398870

Family Applications (1)

Country Status (28)

Families Citing this family (2)

Family Cites Families (6)

• 2014
  • 2014-07-24 JO JOP/2014/0234A patent/JO3371B1/ar active
  • 2014-07-25 LT LTEP14755464.6T patent/LT3024829T/lt unknown
  • 2014-07-25 MY MYPI2016700251A patent/MY183429A/en unknown
  • 2014-07-25 RS RS20171214A patent/RS56604B1/sr unknown
  • 2014-07-25 CN CN201480041380.1A patent/CN105492441B/zh active Active
  • 2014-07-25 TW TW103125533A patent/TWI640542B/zh active
  • 2014-07-25 BR BR112016000436-1A patent/BR112016000436B1/pt active IP Right Grant
  • 2014-07-25 ES ES14755464.6T patent/ES2656039T3/es active Active
  • 2014-07-25 AU AU2014292860A patent/AU2014292860B2/en active Active
  • 2014-07-25 US US14/647,357 patent/US10131692B2/en active Active
  • 2014-07-25 JP JP2016530091A patent/JP6387095B2/ja active Active
  • 2014-07-25 PL PL14755464T patent/PL3024829T3/pl unknown
  • 2014-07-25 WO PCT/US2014/048317 patent/WO2015013690A1/en active Application Filing
  • 2014-07-25 PT PT147554646T patent/PT3024829T/pt unknown
  • 2014-07-25 HU HUE14755464A patent/HUE035252T2/en unknown
  • 2014-07-25 MX MX2016000525A patent/MX363355B/es unknown
  • 2014-07-25 EP EP14755464.6A patent/EP3024829B1/en active Active
  • 2014-07-25 EA EA201690219A patent/EA029392B1/ru not_active IP Right Cessation
  • 2014-07-25 DK DK14755464.6T patent/DK3024829T3/en active
  • 2014-07-25 SG SG11201600031RA patent/SG11201600031RA/en unknown
  • 2014-07-25 CA CA2919208A patent/CA2919208A1/en not_active Abandoned
  • 2014-07-25 KR KR1020167003247A patent/KR102198130B1/ko active IP Right Grant
  • 2014-07-25 SI SI201430496T patent/SI3024829T1/en unknown
• 2016
  • 2016-01-07 PH PH12016500044A patent/PH12016500044A1/en unknown
  • 2016-01-08 ZA ZA2016/00145A patent/ZA201600145B/en unknown
  • 2016-01-22 IL IL243730A patent/IL243730B/en active IP Right Grant
  • 2016-06-08 HK HK16106599.4A patent/HK1218647A1/zh unknown
• 2018
  • 2018-01-04 HR HRP20180009TT patent/HRP20180009T1/hr unknown
  • 2018-09-27 US US16/145,073 patent/US10745443B2/en active Active

Also Published As

Similar Documents